Taiwain Expects To Use U.S. A/H1N1 Flu Sample To Produce Own Vaccine
This article was originally published in PharmAsia News
Executive Summary
Taiwan expects to have a locally developed version of an A/H1N1 vaccine ready by September, drawing on U.S. samples provided to produce a seed stock. Taiwan is having its National Research Institute study the viral samples to watch for mutations. The World Health Organization is expected to ship other samples of the virus strain by the end of May to develop a vaccine. (Click here for more